NEW YORK (GenomeWeb News) – GeneNews and Shanghai Biochip today announced a deal to establish the first Sentinel Centre for Personalized Medicine.

The partners are creating the center, which will be based in Shanghai, in order to co-develop and commercialize products based on GeneNews' gene expression technology called the Sentinel Principle. They inked a memorandum of understanding in February to establish the center.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.